167 related articles for article (PubMed ID: 35625644)
1. Conformational Entropy as a Potential Liability of Computationally Designed Antibodies.
Löhr T; Sormanni P; Vendruscolo M
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625644
[TBL] [Abstract][Full Text] [Related]
2. Contributions of the complementarity determining regions to the thermal stability of a single-domain antibody.
Zabetakis D; Anderson GP; Bayya N; Goldman ER
PLoS One; 2013; 8(10):e77678. PubMed ID: 24143255
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for thermal stability and affinity in a VHH: Contribution of the framework region and its influence in the conformation of the CDR3.
Kinoshita S; Nakakido M; Mori C; Kuroda D; Caaveiro JMM; Tsumoto K
Protein Sci; 2022 Nov; 31(11):e4450. PubMed ID: 36153698
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens.
Al Qaraghuli MM; Ferro VA
J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27862476
[TBL] [Abstract][Full Text] [Related]
5. Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions.
Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM
Protein Eng Des Sel; 2012 Oct; 25(10):591-601. PubMed ID: 22843678
[TBL] [Abstract][Full Text] [Related]
6. CDR1 Composition Can Affect Nanobody Recombinant Expression Yields.
Orlando M; Fortuna S; Oloketuyi S; Bajc G; Goldenzweig A; de Marco A
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572576
[TBL] [Abstract][Full Text] [Related]
7. Positive charge in the complementarity-determining regions of synthetic nanobody prevents aggregation.
Zhong Z; Yang Y; Chen X; Han Z; Zhou J; Li B; He X
Biochem Biophys Res Commun; 2021 Oct; 572():1-6. PubMed ID: 34332323
[TBL] [Abstract][Full Text] [Related]
8. Antigen recognition by single-domain antibodies: structural latitudes and constraints.
Henry KA; MacKenzie CR
MAbs; 2018; 10(6):815-826. PubMed ID: 29916758
[TBL] [Abstract][Full Text] [Related]
9. Backbone flexibility of CDR3 and immune recognition of antigens.
Haidar JN; Zhu W; Lypowy J; Pierce BG; Bari A; Persaud K; Luna X; Snavely M; Ludwig D; Weng Z
J Mol Biol; 2014 Apr; 426(7):1583-99. PubMed ID: 24380763
[TBL] [Abstract][Full Text] [Related]
10. A library approach for the
Arras P; Yoo HB; Pekar L; Schröter C; Clarke T; Krah S; Klewinghaus D; Siegmund V; Evers A; Zielonka S
MAbs; 2023; 15(1):2261149. PubMed ID: 37766540
[TBL] [Abstract][Full Text] [Related]
11. Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold.
Perchiacca JM; Lee CC; Tessier PM
Protein Eng Des Sel; 2014 Feb; 27(2):29-39. PubMed ID: 24398633
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the Diversity of the CDR-H3 Loop Conformational Ensembles in Relationship to Antibody Binding Properties.
Fernández-Quintero ML; Loeffler JR; Kraml J; Kahler U; Kamenik AS; Liedl KR
Front Immunol; 2018; 9():3065. PubMed ID: 30666252
[TBL] [Abstract][Full Text] [Related]
13. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
[TBL] [Abstract][Full Text] [Related]
14. Chemical basis for the affinity maturation of a camel single domain antibody.
De Genst E; Handelberg F; Van Meirhaeghe A; Vynck S; Loris R; Wyns L; Muyldermans S
J Biol Chem; 2004 Dec; 279(51):53593-601. PubMed ID: 15383540
[TBL] [Abstract][Full Text] [Related]
15. High affinity antigen recognition of the dual specific variants of herceptin is entropy-driven in spite of structural plasticity.
Bostrom J; Haber L; Koenig P; Kelley RF; Fuh G
PLoS One; 2011 Apr; 6(4):e17887. PubMed ID: 21526167
[TBL] [Abstract][Full Text] [Related]
16. A novel heavy domain antibody library with functionally optimized complementarity determining regions.
Mandrup OA; Friis NA; Lykkemark S; Just J; Kristensen P
PLoS One; 2013; 8(10):e76834. PubMed ID: 24116173
[TBL] [Abstract][Full Text] [Related]
17. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
[TBL] [Abstract][Full Text] [Related]
18. NanoNet: Rapid and accurate end-to-end nanobody modeling by deep learning.
Cohen T; Halfon M; Schneidman-Duhovny D
Front Immunol; 2022; 13():958584. PubMed ID: 36032123
[TBL] [Abstract][Full Text] [Related]
19. Structural Classification of CDR-H3 in Single-Domain V
Kuroda D; Tsumoto K
Methods Mol Biol; 2023; 2552():61-79. PubMed ID: 36346585
[TBL] [Abstract][Full Text] [Related]
20. Structural diversity in a human antibody germline library.
Teplyakov A; Obmolova G; Malia TJ; Luo J; Muzammil S; Sweet R; Almagro JC; Gilliland GL
MAbs; 2016; 8(6):1045-63. PubMed ID: 27210805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
